• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Glaukos Corp (NY: GKOS )

    143.04 +1.29 (+0.91%)
    Official Closing Price Updated: 7:00 PM EST, Nov 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Glaukos Corp

    < Previous 1 2 3 4 5 6 7 8 Next >
    10 Analysts Have This to Say About Glaukos
    Via Benzinga
    What 10 Analyst Ratings Have To Say About Glaukos
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
    Via Benzinga
    Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants
    This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE). 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
    Via Benzinga
    7 Analysts Have This to Say About Glaukos
    Via Benzinga
    Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
    Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5.  Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on... 
    Via Benzinga
    Analyst Ratings for Glaukos
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
    Via Benzinga
    Where Glaukos Stands With Analysts
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Glaukos
    Analysts have provided the following ratings for Glaukos (NYSE:GKOS) within the last quarter: 
    Via Benzinga
    Glaukos Announces Participation in the Stephens Annual Investment Conference
    From Glaukos Corporation
    Via Business Wire
    Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
    U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
    Via Benzinga
    Glaukos Corporation Announces Third Quarter 2022 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock
    Via Benzinga
    Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate
    Via Benzinga
    Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment
    Via Benzinga
    Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November 2
    From Glaukos Corporation
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
    Via Benzinga
    Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
    Gainers 
    Via Benzinga
    Dow Jumps 450 Points; UiPath Shares Slide
    U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday. 
    Via Benzinga
    Dow Up 249 Points, Nasdaq Set To Snap Skid
    Stocks are charging higher this afternoon, though investors are still awaiting the release of the Federal Reserve's Beige Book. 
    Via Talk Markets
    Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. 
    Via Benzinga
    Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday
      
    Via Benzinga
    What's Going On With Glaukos Shares?
    Glaukos Corp (NYSE: GKOS) shares are trading higher by 1.87% to $49.00 Wednesday morning after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved... 
    Via Benzinga
    Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces Participation in the Wells Fargo Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.